Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer

Cancer Treatment Reviews(2020)10.1016/j.ctrv.2020.102021Source: DataRank Database

Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer is a research paper published in Cancer Treatment Reviews (2020). On theSindex it has a DataRank of 0. It has been cited 169 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access169 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 8.90)OA: greenTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Erika J. Lampert ORCID,Cynthia Coots,Jungmin Lee ORCID,Tzu‐Ting Huang ORCID

Live enrichment

PubMed:32311593 PMC:PMC7272282 OpenAlex:https://openalex.org/W3015444296

Intramural NIH HHS

Grant: ZIA BC011525

National Cancer Institute

FWCI

8.90

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7272282

publisherhttps://api.elsevier.com/content/article/PII:S0305737220300591?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0305737220300591?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ctrv.2020.102021

Fields of Study

PARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentBRCA gene mutations in cancer

MeSH Terms

Phosphoinositide-3 Kinase InhibitorsAnimalsDNA DamageDNA ReplicationFemaleHumansOvarian NeoplasmsSignal TransductionPhosphatidylinositol 3-KinasesMolecular Targeted Therapy

Keywords

MedicineOvarian cancerDNA damageCancer researchPI3K/AKT/mTOR pathwayOncologyTherapeutic windowDNACancerInternal medicinePharmacologyApoptosisGeneticsDNA repaircell cycle checkpointDna Damage Response

Sustainable Development Goals

SDG 0: Good health and well-being

Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer

FAIR Checklist

Authors (4)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)